Marker Therapeutics Inc (MRKR)

[microcapbiotech]

The two stand out statements in the new updates.

#1 - The repeated statement: "No incidence of cytokine release syndrome, neurotoxicity or any other serious adverse events related to the therapy."

#2 - The high complete responses, the high durable responses, and the low disease progression.

I'm not sure what more investors or potential patients can possible want other than unrealistic magical perfection which will never happen with any companies treatments.